BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20680679)

  • 1. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study.
    Maaskant-Braat AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Roumen RM; Nolthenius-Puylaert MC; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2011 May; 127(1):195-203. PubMed ID: 20680679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
    Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
    Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of sentinel node biopsy and stage migration of breast cancer.
    van der Heiden-van der Loo M; Bezemer PD; Hennipman A; Siesling S; van Diest PJ; Bongers V; Peeters PH
    Eur J Surg Oncol; 2006 Sep; 32(7):710-4. PubMed ID: 16765560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage migration due to introduction of the sentinel node procedure: a population-based study.
    Maaskant AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Tutein Nolthenius-Puylaert MC; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2009 Jan; 113(1):173-9. PubMed ID: 18259855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
    Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
    van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
    Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.
    Kuijt GP; Voogd AC; van de Poll-Franse LV; Scheijmans LJ; van Beek MW; Roumen RM
    Eur J Surg Oncol; 2005 Jun; 31(5):500-5. PubMed ID: 15922886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
    Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
    Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.
    Colleoni M; Rotmensz N; Peruzzotti G; Maisonneuve P; Mazzarol G; Pruneri G; Luini A; Intra M; Veronesi P; Galimberti V; Torrisi R; Cardillo A; Goldhirsch A; Viale G
    J Clin Oncol; 2005 Mar; 23(7):1379-89. PubMed ID: 15735114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of micrometastases in the sentinel node of patients with invasive breast cancer.
    Hansen NM; Grube B; Ye X; Turner RR; Brenner RJ; Sim MS; Giuliano AE
    J Clin Oncol; 2009 Oct; 27(28):4679-84. PubMed ID: 19720928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer.
    Leidenius MH; Vironen JH; Heikkilä PS; Joensuu H
    Ann Surg Oncol; 2010 Jan; 17(1):254-62. PubMed ID: 19816743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients.
    Tjan-Heijnen VC; Pepels MJ; de Boer M
    Breast Dis; 2010; 31(2):107-13. PubMed ID: 21368373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.